hsg logo white

HD InsightsEditor’s Letter

Welcome to the fourth edition of HD Insights!

We started the venture of this periodical in 2011 and we have received great feedback on the first three issues. We electronically distribute every issue to over 1300 investigators, researchers, clinicians, and industry leaders from around the globe. In addition to electronic distribution, in 2011, 300 hard copies were distributed at the Huntington Study Group meeting in Indianapolis, Indiana, USA. In 2012, 700 hard copies were distributed at the European Huntington Disease Network meeting in Stockholm, Sweden; and also in 2012, 300 hard copies were distributed at the Huntington Study Group Meeting in Seattle, Washington, USA.

Past issues of HD Insights are available at www.hdinsights.org . They include interviews with leaders in the field such as Dr. Nancy Wexler, Professor of Neuropsychology at Columbia University, and Dr. Walter Koroshetz, the Deputy Director of the NINDS. There are articles on how many people in the world have HD; the therapeutic promises and challenges of antisense oligonucleotides; profiles of companies developing therapies for HD, such as Prana Biotechnology and Isis Pharmaceuticals; and status updates of HD clinical trials, the only comprehensive status report of HD clinical trials globally.

In this issue and the previous issue, we have included features on HD research in Chile and Japan. If you or one of your colleagues are interested in contributing a piece that highlights HD research in your part of the globe, please email me at editor@hdinsights.org . To receive a free subscription to HD Insights, simply email subscribe@hdinsights.org . If you have feedback for HD Insights, if there are features you would like to see in the next issue, if you want to contribute an article, or if you are eager to support this periodical, please email me.

The continuation of this periodical into 2013 has again been made possible by a generous unrestricted educational grant from Lundbeck.

Together we can advance research and eventually therapeutics for Huntington disease.









Ray Dorsey, MD

Editor, HD InsightsTM


Editorial Board Members

Ray Dorsey, MD — Editor, Johns Hopkins University

Donald Kennedy, PhD — Stanford University

Nobuyuki Nukina, MD, PhD — Riken Brain Science Institute

Rodrigo Osorio — Agrupacion Chilena de Huntington

Bernard Ravina, MD — Biogen Idec

Ralf Reilmann, MD — University of Munster S

arah Tabrizi, MBChB, PhD — University College London

Leslie Thompson, PhD — University of California Irvine

Huntington Study Group

Shari Kinel, JD — HSG Executive Director

Liz McCarthy, BA — HSG Administrative Manager

Jillian Lowell, BS — HSG Event Planner


Hitoshi Okazawa, MD, PhD

Justo Garcia de Yebenes, MD

Lise Munsie, PhD

Paige Nichols, BA

Publication Staff

Kristin Darwin, BS — Deputy Editor

Robin Taylor — Production Editor

Martin Holmes — Technical Editor

Todd Bernhard — Copy Editor

Vinayak Venkataraman, BS — Website Designer

Dave Kolko — Distribution Specialist

For more information on HD Insights, or to receive a free subscription, please visit us at www.HDInsights.org  or email us at editor@hdinsights.org

About HD Insights

Our mission is to promote, disseminate, and facilitate research on Huntington’s disease. To fulfill this mission, we are guided by an outstanding editorial board that includes representatives from three continents, academia, industry, and the HD community.